Article Text

Download PDFPDF
Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: clinicopathologic analysis of a case and review of the literature
  1. M. Varras*,
  2. C. Akrivis,
  3. A. Demou,
  4. E. Kitsiou and
  5. N. Antoniou
  1. *Department of Gynaecology, Agios Savas Anticancer Oncologic Hospital, Athens, First District National Health System, Athens, Greece
  2. Department of Obstetrics and Gynaecology, G. Chatzikosta General State Hospital, Ioannina, District National Health System, Epirus, Greece
  3. Department of Pathology, G. Chatzikosta General State Hospital, Ioannina, District National Health System, Epirus, Greece
  1. Address correspondence and reprint requests to: Dr Michail N. Varras, MD, PhD, Consultant in Obstetrics and Gynaecology, Platonos 33, Politia (Kifisia) 14563, Athens, Greece. Email: mnvarras{at}otenet.gr

Abstract

Angiomyofibroblastoma is a rare mesenchymal tumor. This study presents the clinical, histologic, and immunohistochemical features of an angiomyofibroblastoma of the vagina occurring in an 80-year-old breast cancer patient under prolonged treatment with tamoxifen. Histologically, the tumor was characterized by alternating hypercellular and hypocellular edematous zones and small- to medium-sized blood vessels, which were characteristically thin walled. The tumor cells were spindle shaped (mainly) or round shaped (occasionally) arranged in cords and nests. The stroma was edematous and contained inflammatory cells, especially lymphocytes and mast cells. Immunohistochemistry of the tumor cells revealed diffuse and intense immunoreactivity for vimentin and desmin. The staining for estrogen receptors and progesterone receptors was positive, with a percentage of 70% and 40%, respectively. In conclusion, the tumor was diagnosed as an angiomyofibroblastoma based on its typical histologic and immunohistochemical features. The expression of estrogen and progesterone receptors suggests that it might arise as a neoplastic proliferation of hormonally responsible mesenchymal cells. Tamoxifen may exert stimuli effects upon mesenchymal cells.

  • angiomyofibroblastoma
  • breast cancer
  • desmin
  • estrogen receptor
  • immunohistochemistry
  • myoid differentiation
  • progesterone receptor
  • soft tissue tumor
  • tamoxifen
  • vagina
  • vimentin

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.